We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Whole-Brain RT Recommended for Patients with Brain Metastases

By MedImaging International staff writers
Posted on 10 Oct 2019
Print article
A new study shows that patients with brain metastases who received whole-brain radiotherapy (RT) experience fewer neurologic symptoms and better cognition over time when hippocampal neural stem cells are protected.

Researchers at Northwestern Medicine (NM; Winfield, IL, USA) and the Mayo Clinic (Rochester, MN, USA) conducted a study in 518 patients in order to examine the hypothesis that radiation to the hippocampal stem cells plays a role in cognitive decline. To do so, study participants were randomized to whole brain RT plus memantine (a NMDA antagonist used to improve cognition, mood, behavior, and the ability to perform daily activities in moderate to severe Alzheimer's disease), with or without hippocampal avoidance.

The researchers found a 26% relative reduction in risk of cognitive toxicity following whole brain RT with hippocampal avoidance, compared to whole-brain RT. Patients who received treatment that avoided the hippocampus continued to maintain measurable improvements in cognition, with fewer neurologic symptoms, less interference of neurologic symptoms in their daily activities, and less memory problems. Toxicity, intracranial progression-free survival, and overall survival outcomes were similar to those experienced by patients who had whole-brain RT. The study was presented at the American Society for Radiation Oncology annual meeting, held during September 2019 in Chicago (IL, USA).

“These results revolutionize our understanding of the cognitive effects of brain irradiation in a manner that has far-reaching implications in terms of the safer radiotherapy treatment of primary or metastatic brain tumors,” said lead author and study presenter Vinai Gondi, MD, director of research at the NM Proton Center. “Our phase III trial not only provides evidence for practice change in the management of brain metastases, but also builds upon decades of preclinical and clinical research to definitely establish the hippocampus as a radiosensitive and cognition-specific organ at risk during brain irradiation.”

The hippocampus (part of the Limbic system) is a small formation in the temporal lobe responsible for the processing of long-term memory and emotional responses. Certain sub-regions of the hippocampus play roles in different types of memory, such as spatial memories, emotional behavior, and regulation of hypothalamic functions. The hippocampus is one of the unique regions in brain where the neurogenesis continues even in adult life, thanks to neural stem cells that integrate into the mainstream neurons.

Related Links:
Northwestern Medicine
Mayo Clinic

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Oncology Information System
RayCare
Radiology Software
MSK Radiology
New
Portable X-Ray Unit
AJEX240H

Print article

Channels

Ultrasound

view channel
Image: Structure of the proposed transparent ultrasound transducer and its optical transmittance (Photo courtesy of POSTECH)

Ultrasensitive Broadband Transparent Ultrasound Transducer Enhances Medical Diagnosis

The ultrasound-photoacoustic dual-modal imaging system combines molecular imaging contrast with ultrasound imaging. It can display molecular and structural details inside the body in real time without... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.